Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04898855
Other study ID # 2020.05728.BD
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date August 2024

Study information

Verified date March 2024
Source University of Coimbra
Contact Maria Clara
Phone +351 911820289
Email mclara@uc.pt
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to determine the treatment effects, feasibility, and acceptability of an internet-based cognitive-behavioral therapy intervention to improve the sleep of Portuguese cancer survivors with insomnia.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date August 2024
Est. primary completion date July 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18+ years - Provided informed consent - Ability to read and write in Portuguese - Ability to use a computer and/or smartphone, and the internet - History of cancer - Have completed primary cancer treatment (survivors who are on hormone and/or other long-term maintenance therapy agencies are eligible to participate) - Subclinical or significant symptoms of insomnia (ISI scores>8) - Ongoing sleep medication accepted if the dosage has been stable during the last 3 months - No participation in any other interventional study or clinical trial Exclusion Criteria: - Age = 18 years - Absence of clinically or subclinical significant symptoms - No history of cancer - Inability to provide informed consent - Inability to use a computer and/or smartphone - No access to the internet - Another untreated sleep diagnosis - Current major psychiatric or medical condition - Pregnancy or breastfeeding - Parallel ongoing psychological treatment for insomnia - Habitual night shift, or rotating shift-workers

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavioral Therapy for Insomnia
Treatment includes sleep hygiene, sleep restriction, stimulus control, and cognitive therapy.

Locations

Country Name City State
Portugal Center for Research in Neuropsychology and Cognitive and Behavioral Intervention (CINEICC) Coimbra

Sponsors (1)

Lead Sponsor Collaborator
University of Coimbra

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Other Feasibility as assessed by recruitment, retention/attrition data Computed as the number of participants that registered to enroll, dropped out before completing the intervention and completed the intervention Post-intervention (8 weeks after enrollment)
Other Feasibility as assessed by usage (program visit length, completion of activities) Computed as the average duration of participants' visits to the intervention, sleep diary logs, homework activities Post-intervention (8 weeks after enrollment)
Other Acceptability Self-report scales of satisfaction, adherence and perceived helpfulness rated on 4-point Likert scales adapted from Manber et al. (2011) Post-intervention (8 weeks after enrollment)
Other Usability User Experience Questionnaire Post-intervention (8 weeks after enrollment)
Primary Insomnia severity Insomnia Severity Index (overall score 0-28 interpreted as follows: 0-7 absence of insomnia; 8-14 sub-threshold insomnia; 15-21 moderate insomnia; 22-28 severe insomnia) Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Sleep efficiency Sleep Diary Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Total sleep time Sleep Diary Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Number of nocturnal awakenings Sleep Diary Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Wake after sleep onset Sleep Diary Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Sleep onset latency Sleep Diary Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Cancer-related fatigue Multidimensional Fatigue Symptom Inventory-Short Form (overall score 24-96, higher scores denote higher levels of cancer-related fatigue) Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Health-related quality of life European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30; World Health Organization Quality of Life - Brief (overall scores 0-100, higher scores indicate higher quality of life) Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Anxiety Hospital Anxiety and Depression Scale (total subscale 0-21, higher scores denote highest anxiety level) Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
Secondary Depression Hospital Anxiety and Depression Scale (total subscale 0-21, higher scores denote highest depression level) Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients